Literature DB >> 35166980

Colonoscopic reduction of a transanal prolapsed ileocolic intussusception.

Iraj Shahramian1, Fateme Parooie2,3, Seyed Ali Mirabbasi1, Morteza Salarzaei1.   

Abstract

Transanal protrusion of intussusception (TAPI; also known as prolapsed intussusception) is a rare complication. Here, we present a successful colonoscopic reduction of ileocolic intussusception presented with transanal prolapse. An 8‑month male child, weighing 8 kg, was referred to our hospital presenting with a mass in his anal canal, diarrhea and rectal bleeding for two days. The sonographic evaluation revealed an ileocolic intussusception in the rectosigmoid area. The patient was treated using colonoscopic reduction. To our knowledge, this is the first study reporting colonoscopic reduction for transanal prolapsed intussusceptions. Our study suggests gastroenterologists to consider colonoscopy as a therapeutic method for prolapsed intussusceptions and encourages them to attempt reducing the invagination using this method before laparotomy, especially in cases presenting within 48 h of onset of symptoms and no peritonitis symptoms.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, ein Teil von Springer Nature.

Entities:  

Keywords:  Intestinal blockage; Intestinal invagination; Invagination; Pediatric; Telescoping sign

Mesh:

Year:  2022        PMID: 35166980     DOI: 10.1007/s10354-022-00915-4

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  1 in total

Review 1.  Management of intussusception in children: A systematic review.

Authors:  Lorraine I Kelley-Quon; L Grier Arthur; Regan F Williams; Adam B Goldin; Shawn D St Peter; Alana L Beres; Yue-Yung Hu; Elizabeth J Renaud; Robert Ricca; Mark B Slidell; Amy Taylor; Caitlin A Smith; Doug Miniati; Juan E Sola; Patricia Valusek; Loren Berman; Mehul V Raval; Ankush Gosain; Matthew B Dellinger; Stig Sømme; Cynthia D Downard; Jarod P McAteer; Akemi Kawaguchi
Journal:  J Pediatr Surg       Date:  2020-10-06       Impact factor: 2.545

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.